Verster Joris C, Volkerts Edmund R, Olivier Berend, Johnson William, Liddicoat Laura
University of Utrecht, Utrecht Institute for Pharmaceutical Sciences, Department of Psychopharmacology, P.O. Box 80082, 3508 TB Utrecht, The Netherlands.
Curr Drug Saf. 2007 Sep;2(3):220-6. doi: 10.2174/157488607781668882.
Zolpidem is among the most frequently prescribed hypnotic drugs for those who suffer from insomnia. Recent media reports drew attention to driving impairment after zolpidem misuse. This review summarizes the available data on the effects of recommended use and misuse of zolpidem on driving ability and traffic safety. Both experimental studies and roadside evidence were taken into account. From these studies it must be concluded that patients should fully comply with the prescription instructions of zolpidem, i.e. to take the medication just prior to a full 8 hours of uninterrupted sleep. If this strategy is adopted, zolpidem is a safe alternative to benzodiazpine hypnotics and zopiclone who do show significant driving impairment the morning following bedtime administration. However, to ensure traffic safety higher dosages than recommended (10 mg) or allowing less than 8 hours between zolpidem intake and actual operation of a motor vehicle should be avoided.
唑吡坦是为失眠患者开具的最常用催眠药物之一。最近的媒体报道引起了人们对唑吡坦滥用后驾驶能力受损的关注。这篇综述总结了关于唑吡坦推荐使用和滥用对驾驶能力及交通安全影响的现有数据。实验研究和路边证据均被纳入考虑。从这些研究中可以得出结论,患者应完全遵守唑吡坦的处方说明,即在保证有整整8小时不间断睡眠之前服用该药物。如果采用这种策略,唑吡坦是苯二氮䓬类催眠药和佐匹克隆的安全替代品,后两者在睡前服用后次日早晨确实会导致明显的驾驶能力受损。然而,为确保交通安全,应避免使用高于推荐剂量(10毫克)的唑吡坦,或在服用唑吡坦与实际驾驶机动车之间间隔少于8小时。